Chemical Compound

2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide

CAS Registry Number 583840-03-3
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide 结构式
Primary record

2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide

库存
3,391 克
纯度
99.6 %
CAS
583840-03-3

化合物标识与属性

CAS
583840-03-3
PubChem CID
9826472
SMILES
CNC(=O)C1=[N+](C=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)[O-]
Canonical SMILES
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)cc[n+]1[O-]

名称与同义词

  • Sorafenib N-Oxide
  • Srf-nox
  • Sorafenib N oxide
  • Sorafenib-N-oxide
  • 583840-03-3
  • Sorafenib metabolite M2
  • Sorafenib Impurity 22
  • 5XYK65KIGD
  • RefChem:184377
  • Sorafenib major metabolite
  • Sorafenib Tosylate N-Oxide
  • SCHEMBL548256
  • DTXSID60431376
  • orb1693535
  • BAY-673472
  • SCHEMBL29733289
  • CTK8E8479
  • DTXCID10382208
  • BQAZCCVUZDIZDC-UHFFFAOYSA-N
  • ZINC3817152
  • BAY-67-3472
  • J2.910.287B
  • CID9826472
  • FS27857
  • CID 9826472
  • lithium,3,4-dimethyl-2H-thiophen-2-ide
  • RT-015755
  • CS-0132815
  • FT-0674634
  • 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide
  • G92139
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxidopyridin-1-ium-2-carboxamide
  • Q27263023
  • 1-[4-[(4-nitrophenyl)methylidene]pyridin-1-yl]ethanone
  • 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide
  • 2-Pyridinecarboxamide, 4-(4((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)N-methyl-,1-oxide
  • 4-(4-(((4-Chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-methylpyridine-2-carboxamide 1-oxide
  • ((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl]-dicyclohexylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (S,S)-[COD]Ir[c
  • 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide
  • 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate
  • 4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL}AMINO)PHENOXY]-2-(METHYLCARBAMOYL)PYRIDIN-1-IUM-1-OLATE
  • 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methyl-1-oxo-1lambda~5~-pyridine-2-carboxamide
  • 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-2-(methylaminocarbonyl)pyridine 1-oxide
  • 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-2-(methylcarbamoyl)pyridine 1-oxide
  • 583844-38-6
  • 58385-52-7
  • 583855-46-3